These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 8744566)

  • 1. BOOMSLANG: a program for combinatorial structure generation.
    Cosgrove DA; Kenny PW
    J Mol Graph; 1996 Feb; 14(1):1-5, 23. PubMed ID: 8744566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AstexViewer: a visualisation aid for structure-based drug design.
    Hartshorn MJ
    J Comput Aided Mol Des; 2002 Dec; 16(12):871-81. PubMed ID: 12825620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Active-site-directed 3D database searching: pharmacophore extraction and validation of hits.
    Clark DE; Westhead DR; Sykes RA; Murray CW
    J Comput Aided Mol Des; 1996 Oct; 10(5):397-416. PubMed ID: 8951650
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and screening of a polyketide virtual library for drug leads against a motilide pharmacophore.
    Siani MA; Skillman AG; Carreras CW; Ashley G; Kuntz ID; Santi DV
    J Mol Graph Model; 2000; 18(4-5):497-511, 539-40. PubMed ID: 11143565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Twelfth annual conference of the Molecular Graphics Society. Interlaken, 7-11 June 1993.
    Weber J
    J Mol Graph; 1993 Dec; 11(4):252-6. PubMed ID: 8136329
    [No Abstract]   [Full Text] [Related]  

  • 6. Computational combinatorial ligand design: application to human alpha-thrombin.
    Caflisch A
    J Comput Aided Mol Des; 1996 Oct; 10(5):372-96. PubMed ID: 8951649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Meeting on binding sites: characterizing and satisfying steric and chemical restraints. University of York, 28-30 March 1993.
    Slater T; Timms D
    J Mol Graph; 1993 Dec; 11(4):248-51. PubMed ID: 8136328
    [No Abstract]   [Full Text] [Related]  

  • 8. Bioactive design: forward to new frontiers.
    Weber HP
    J Comput Aided Mol Des; 1994 Feb; 8(1):1-3. PubMed ID: 8035209
    [No Abstract]   [Full Text] [Related]  

  • 9. Recent developments in de novo design and scaffold hopping.
    Mauser H; Guba W
    Curr Opin Drug Discov Devel; 2008 May; 11(3):365-74. PubMed ID: 18428090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New 4-point pharmacophore method for molecular similarity and diversity applications: overview of the method and applications, including a novel approach to the design of combinatorial libraries containing privileged substructures.
    Mason JS; Morize I; Menard PR; Cheney DL; Hulme C; Labaudiniere RF
    J Med Chem; 1999 Aug; 42(17):3251-64. PubMed ID: 10464012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ALADDIN: an integrated tool for computer-assisted molecular design and pharmacophore recognition from geometric, steric, and substructure searching of three-dimensional molecular structures.
    Van Drie JH; Weininger D; Martin YC
    J Comput Aided Mol Des; 1989 Sep; 3(3):225-51. PubMed ID: 2573695
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conformational analysis of D1 dopamine receptor agonists: pharmacophore assessment and receptor mapping.
    Mottola DM; Laiter S; Watts VJ; Tropsha A; Wyrick SD; Nichols DE; Mailman RB
    J Med Chem; 1996 Jan; 39(1):285-96. PubMed ID: 8568818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploring the P2 and P3 ligand binding features for hepatitis C virus NS3 protease using some 3D QSAR techniques.
    Wei HY; Lu CS; Lin TH
    J Mol Graph Model; 2008 Apr; 26(7):1131-44. PubMed ID: 18024210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incorporating partial matches within multi-objective pharmacophore identification.
    Cottrell SJ; Gillet VJ; Taylor R
    J Comput Aided Mol Des; 2006 Dec; 20(12):735-49. PubMed ID: 17203366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The World Wide Web as a graphical user interface to program macros for molecular graphics, molecular modeling, and structure-based drug design.
    Taylor NR; Smith R
    J Mol Graph; 1996 Oct; 14(5):291-6, 280-2. PubMed ID: 9097235
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LEA3D: a computer-aided ligand design for structure-based drug design.
    Douguet D; Munier-Lehmann H; Labesse G; Pochet S
    J Med Chem; 2005 Apr; 48(7):2457-68. PubMed ID: 15801836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Computer-aided design of chiral ligands. Part III. A novel ligand for asymmetric allylation designed using computational techniques.
    Kozlowski MC; Waters SP; Skudlarek JW; Evans CA
    Org Lett; 2002 Dec; 4(25):4391-3. PubMed ID: 12465895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Computer-aided design of polyketides with the required properties].
    Sergeĭko AP; Stepanchikova AV; Sobolev BN; Zotchev SB; Lagunin AA; Filimonov DA; Poroĭkov VV
    Biomed Khim; 2007; 53(5):522-31. PubMed ID: 18078066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug Guru: a computer software program for drug design using medicinal chemistry rules.
    Stewart KD; Shiroda M; James CA
    Bioorg Med Chem; 2006 Oct; 14(20):7011-22. PubMed ID: 16870456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent trends in library design: 'rational design' revisited.
    Schnur DM
    Curr Opin Drug Discov Devel; 2008 May; 11(3):375-80. PubMed ID: 18428091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.